Room 221
Sponsored by Bristol Myers Squibb and Johnson & Johnson Alliance

Saturday, March 28

10:45 – 11:45 a.m.
4320. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases

2:45 – 3:45 p.m.
4323. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases

Sunday, March 29

9:45 – 10:45 a.m.
4321. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases

3 – 4 p.m.
4324. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases

Room 222
Sponsored by GE Healthcare

Saturday, March 28

9 – 9:30 a.m.
4300. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speaker:

Mahmoud Al Rifai, MD
Houston Methodist

10 – 10:30 a.m.
4301. Heart Disease in Women

Speaker:

Rupa M. Sanghani, MD
Rush

11 – 11:30 a.m.
4302. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

Noon – 12:30 p.m.
4303. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

1 – 1:30 p.m.
4304. Heart in Motion: The Value of Exercise Stress With PET For Adult Congenital Patients
Discover how exercise stress testing combined with cardiac PET imaging can unlock deeper insights into myocardial perfusion and functional reserve in adults with congenital heart disease. This interactive learning lab will explore the clinical rationale, workflow considerations, and emerging evidence supporting exercise stress PET as a powerful tool for risk stratification and personalized care. Join us to understand why moving beyond pharmacologic stress can make a meaningful difference in complex congenital cases.

Speaker:

Jamie Bourque, MD
UVA

3 – 3:30 p.m.
4305. Implementing Shared Cardiac PET Services: Operational Considerations
This session explores the practical steps for launching and managing shared cardiac PET services across multiple sites or departments. Learn how to design workflows that optimize efficiency, coordinate between cardiology and nuclear medicine teams, and ensure smooth scheduling and patient throughput. Real-world examples will highlight strategies for overcoming common operational challenges.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

3:30 – 4 p.m.
4306. Implementing Shared Cardiac PET Services: Technical Considerations
Dive into the technical aspects of shared cardiac PET implementation, including equipment requirements, tracer logistics, image acquisition protocols, and quality assurance standards. This session will address how to maintain consistency across sites, leverage technology for scalability, and ensure compliance with accreditation guidelines.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

4 – 4:30 p.m.
4307. Implementing Shared Cardiac PET Services: Building a Sustainable Business Case
Understand the financial framework for shared cardiac PET services, from cost modeling and budgeting to reimbursement models. This session will provide insights into building a sustainable business case, understanding and addressing payor requirements, and identifying opportunities for efficiencies and cost-sharing.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

Sunday, March 29

9:30 – 10 a.m.
4308. Implementing Shared Cardiac PET Services: Operational Considerations
This session explores the practical steps for launching and managing shared cardiac PET services across multiple sites or departments. Learn how to design workflows that optimize efficiency, coordinate between cardiology and nuclear medicine teams, and ensure smooth scheduling and patient throughput. Real-world examples will highlight strategies for overcoming common operational challenges.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

10 – 10:30 a.m.
4309. Implementing Shared Cardiac PET Services: Technical Considerations
Dive into the technical aspects of shared cardiac PET implementation, including equipment requirements, tracer logistics, image acquisition protocols, and quality assurance standards. This session will address how to maintain consistency across sites, leverage technology for scalability, and ensure compliance with accreditation guidelines.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom
10:30 – 11 a.m.
4310. Implementing Shared Cardiac PET Services: Building a Sustainable Business Case
Understand the financial framework for shared cardiac PET services, from cost modeling and budgeting to reimbursement models. This session will provide insights into building a sustainable business case, understanding and addressing payor requirements, and identifying opportunities for efficiencies and cost-sharing.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

11:30 a.m. – Noon
4311. Heart in Motion: The Value of Exercise Stress With PET For Adult Congenital Patients
Discover how exercise stress testing combined with cardiac PET imaging can unlock deeper insights into myocardial perfusion and functional reserve in adults with congenital heart disease. This interactive learning lab will explore the clinical rationale, workflow considerations, and emerging evidence supporting exercise stress PET as a powerful tool for risk stratification and personalized care. Join us to understand why moving beyond pharmacologic stress can make a meaningful difference in complex congenital cases.

Speaker:

Lawrence Phillips, MD, MASNC
NYU Langone

12:30 – 1 p.m.
4312. Heart Disease in Women

Speaker:

Rupa M. Sanghani, MD
Rush

1:30 – 2 p.m.
4313. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speaker:

Mahmoud Al Rifai, MD
Houston Methodist

2:30 – 3 p.m.
4314. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

3:30 – 4 p.m.
4315. AI in ECG: Clinical Impact and Workflow

Speaker:

Abhishek J. Deshmukh, MBBS
Mayo Clinic

4:30 – 5 p.m.
4316. AI in ECG: Clinical Impact and Workflow

Speaker:

Abhishek J. Deshmukh, MBBS
Mayo Clinic

Monday, March 30

9 – 9:30 a.m.
4317. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

10 – 10:30 a.m.
4318. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

11 – 11:30 a.m.
4319. Heart in Motion: The Value of Exercise Stress With PET For Adult Congenital Patients
Discover how exercise stress testing combined with cardiac PET imaging can unlock deeper insights into myocardial perfusion and functional reserve in adults with congenital heart disease. This interactive learning lab will explore the clinical rationale, workflow considerations, and emerging evidence supporting exercise stress PET as a powerful tool for risk stratification and personalized care. Join us to understand why moving beyond pharmacologic stress can make a meaningful difference in complex congenital cases.

Speaker:

Jamie Bourque, MD
UVA

1:30 – 2 p.m.
4349. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speaker:

Mahmoud Al Rifai, MD
Houston Methodist

Room 225
Sponsored by GE Healthcare

Saturday, March 28

9 a.m. – 5 p.m.
4360. Title to be Announced

Sunday, March 29

9 a.m. – 5 p.m.
4361. Title to be Announced

Monday, March 30

9 a.m. – 5 p.m.
4362. Title to be Announced

Room 223
Sponsored by Pfizer

Saturday, March 28

2 – 3 p.m.
4380. Getting ATTR-CM Nuclear Scintigraphy Right: Practical Guidance For Clinical Practice
Cardiac nuclear scintigraphy is central to the noninvasive diagnosis of ATTR‑CM, yet variability in acquisition and interpretation can affect diagnostic confidence. This session provides practical guidance on appropriate clinical suspicion, optimization of SPECT‑based image acquisition, and accurate interpretation of PYP/HMDP studies. Using illustrative cases, faculty will highlight key principles, common pitfalls, and best practices to support appropriate use of nuclear imaging.

3:15 – 4:15 p.m. 4382. Optimizing ATTR-CM Care: Interpreting Change Over Time
Transthyretin amyloid cardiomyopathy (ATTR‑CM) is a progressive disease in which clinical, imaging, and laboratory findings may evolve at different rates. This session focuses on optimizing longitudinal patient care using a guidance‑informed approach to interpreting change over time. Through case-based discussion, faculty will explore how to navigate disease progression, emphasizing thoughtful assessment of symptoms, functional status, imaging, and biomarkers within the broader clinical context.

Sunday, March 29

10:45 – 11:45 a.m.
4381. Optimizing ATTR-CM Care: Interpreting Change Over Time
Transthyretin amyloid cardiomyopathy (ATTR‑CM) is a progressive disease in which clinical, imaging, and laboratory findings may evolve at different rates. This session focuses on optimizing longitudinal patient care using a guidance‑informed approach to interpreting change over time. Through case-based discussion, faculty will explore how to navigate disease progression, emphasizing thoughtful assessment of symptoms, functional status, imaging, and biomarkers within the broader clinical context.

Room 227
Sponsored by Boston Scientific

Saturday, March 28

10 a.m. – Noon
4340. AGENT Virtual Reality Case Experience
Step into the lab and experience a previously recorded live case in virtual reality to learn from operators firsthand. Cases are 30 mins and will begin at 10 a.m., 10:30 a.m., 11 a.m., and 11:30 a.m.

12:30 – 1:30 p.m.
4341. Breaking NEWS in PE: HI-PEITHO Clinical Trial Results – Implications to Patient Care
In this session, a multidisciplinary panel of leaders in pulmonary embolism will examine the results and real-world impact of the recent HI-PEITHO data release. This multi-country, multicenter landmark RCT was designed and conducted in partnership between society, industry, and academia to achieve impactful results through robust study design and large patient population to address to answer the biggest questions in pulmonary embolism care today.

Speakers:

Michael R. Jaff, DO, FACP, FACC (Moderator)

Erik Klok, MD, PhD

Stavros Konstantinides, MD, FESC

Peter Monteleone, MD, FACC, FSCAI

Soophia Naydenov, MD, FCCP

Gregory Piazza, MD, MS

Kenneth Rosenfield, MD, MSC, MHCDS, MSCAI

Andrew Sharp, MBChB, MD, FRCP

Michael Young, MD, FSCAI, RPVI

2:30 – 3:30 p.m.
4342. Calcium IVUS Image Interpretation Laptop Session
Want to use your Boston IVUS like a pro? Join one of our laptop sessions where we'll walk you through the AVVIGO+ interface, share workflow tips, and use case examples to sharpen your IVUS interpretation skills. Seats are limited and will be assigned on a first-come, first-served basis.

4 – 5 p.m.
4343. Title to be Announced

Sunday, March 29

9:30 – 11 a.m.
4344. ROTAPRO Virtual Reality Case Experience
Step into the lab and experience a previously recorded live case in virtual reality to learn from operators firsthand. Cases are 30 mins and will begin at 9:30 a.m., 10 a.m., 10:30 a.m., and 11 a.m.

11:45 a.m. – 1 p.m.
4345. Renal Denervation in Hypertension Care: Evidence, Innovation, and What's Next
This symposium will examine hypertension as a persistent global health challenge and the ongoing need for novel treatment approaches. The session will review the current renal denervation evidence base, highlighting how clinical trial data have shaped the therapy's evolution. Attendees will learn about emerging ultrasound-based renal denervation techniques, including early experience with TIVUS, and explore how upcoming evidence from the THRIVE trial may further define the role of RDN in clinical practice. The program will provide a forward-looking perspective on how innovation and evidence may reshape hypertension management strategies.

Speakers:

Florian Rader, MD

Andrew Sharp, MD

1:30 – 2:30 p.m.
4346. ISR IVUS Image Interpretation Laptop Session
Want to use your Boston IVUS like a pro? Join one of our laptop sessions where we'll walk you through the AVVIGO+ interface, share workflow tips, and use case examples to sharpen your IVUS interpretation skills. Seats are limited and will be assigned on a first-come, first-served basis.

4 – 5 p.m.
4347. Elevating AFib Care For Veteran Patients
With a special focus on veteran patients, this program is for electrophysiologists, interventional cardiologists, referring clinicians, and AFib program leaders committed to scalable, system-level improvement even in resource-constrained environments. This compelling program guided by the Four Pillars of atrial fibrillation (AFib) management showcases how evidence-based, fully integrated AFib solutions can unlock greater access, streamline care delivery, and elevate outcomes for patients. Beginning with a candid "State of the State" on AFib care, Dr. Creighton Don will examine the burden of disease and where innovation can meaningfully elevate care delivery. Dr. Brad Sutton will bring the evidence to life, translating data insights into practical, real-world strategies that empower confident, consistent, data-driven decisions. An expert panel of VA physicians will demonstrate how scalable program design, state-of-the-art ablation and LAAC technologies, and coordinated long-term management can work together to build a seamless, end-to-end AF pathway.

Speakers:

Creighton W. Don, MD MPH

Brad Sutton, MD, CMO
AF Solutions, Boston Scientific

Monday, March 30

9 a.m. – Noon
4348. LUX-Dx Hands-On Training Session